This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
A Liver Biopsy Is A Procedure In Which A Small Piece Of Tissue Is Taken From The Liver To Be Examined Under A Microscope. It Is Typically Performed To Diagnose And Evaluate A Variety Of Conditions Affecting The Liver, Including Inflammation, Infection, Cirrhosis, And Cancer. The Most Common Technique For Obtaining A Liver Biopsy Is To Insert A Needle Through The Abdomen And Into The Liver. Ultrasound Or Other Imaging Techniques Are Used To Help Guide The Needle Into The Correct Location. The Sample Of Liver Tissue Is Then Removed And Sent To A Laboratory For Analysis. Additional Techniques May Be Used In Some Cases, Including Transvenous Biopsy And Laparoscopic Biopsy. In Transvenous Biopsy, A Needle Is Passed Into A Vein That Leads To The Liver. Laparoscopic Biopsy Involves Making A Small Incision In The Abdomen And Using A Tiny Camera To View The Liver And Take Samples Of Tissue. The Risks Associated With A Liver Biopsy Are Generally Minimal. The Most Common Complication Is Bleeding, Which Can Be Treated With Medications Or Other Procedures. In Rare Cases, Infection Or Damage To The Liver May Occur. Overall, A Liver Biopsy Is A Safe And Effective Procedure Used To Diagnose And Evaluate Liver Diseases. It Is Important To Discuss The Potential Risks And Benefits Of The Procedure With Your Doctor Before Deciding If It Is Right For The Patient.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States